GlassScriptPhysician profile
Daniel G Schwartz
NPI 1003063165
$423,854.48
in general payments reported to CMS, 2019-2025
14 companies · $49K in 2025
The $49K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $386 · 2021: $108K · 2022: $107K · 2023: $80K · 2024: $55K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $162K · Travel and Lodging: $19K · Food and Beverage: $3,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $161,805.05 |
| Travel and Lodging | $19,186.15 |
| Food and Beverage | $3,486.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $215,475.19 | 2019-2025 | Milagro, Inhance |
| Encore Medical, LP | $190,786.58 | 2019-2025 | Djo Surgical |
| Depuy Synthes Products, INC. | $13,305.48 | 2021-2022 | |
| Depuy Synthes Sales INC. | $3,130.05 | 2019-2025 | Gryphon Orthocord, Na, Healix Knotless Peek |
| Stryker Corporation | $467.56 | 2024 | Blueprint Patient Specific Instrumentation, Aequalis Ascend Flex, Aequalis Flex Revive |
| Insight Medical Systems, INC. | $212.50 | 2022 | |
| Zimmer Biomet Holdings, INC. | $135.13 | 2020 | |
| Treace Medical Concepts, INC. | $130.00 | 2024 | |
| Next Science LLC | $120.23 | 2021 | |
| Invictus Surgical Incorporated | $38.56 | 2025 | |
| Amgen INC. | $19.83 | 2019 | |
| Horizon Therapeutics Plc | $18.52 | 2019 | |
| Ossio INC | $14.85 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$133,786.31 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.